InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,600.20
(
0.42%
)
US TECH 100
19,996.40
(
0.43%
)
Dow Jones
39,406.76
(
0.29%
)
Brent Oil
85.12
(
0.50%
)
Bitcoin
57,896.08
(
-0.21%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: lumpy9200 post# 4930

Sunday, 10/21/2007 1:29:34 AM

Sunday, October 21, 2007 1:29:34 AM

Post# of 12660
OT-I don't have any doubts that orBec improves the clinical benefit over prednisone. Pazdur's comments left the door open, and one could have taken advantage by buying soon after the negative panel vote and selling before PDUFA date. I don't remember if they extended right at the first PDUFA date or a few days before. Anyway, it's too bad for the patients that neither orBec nor Provenge is on the market.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up